PitchSend

Investor Presentaiton

REDUCES THE RECURRENCE OF NON-INFECTIOUS UVEITIS YUTIQ Median Time to Recurrence: 1051 Days 0.7 0.6 0.5 0.4 0.3 0.2 28 n N 1.0 0.9 0.8 Probability Recurrence 0.0 0 Nasdaq: ALIM ww 60 60 Sham Injection N=42 Median Time 95 Days YUTIQ Injection N=87 alimera 0.18 mg YUTIQ (fluocinolone acetonide intravitreal implant) 0.18 mg Days Post Injection 3 Year Implant Depletion Alimera data on file from PSV-FAI-001 11

View entire presentation